Veradigm (NASDAQ:MDRX) Sees Strong Trading Volume – Time to Buy?

Veradigm Inc. (NASDAQ:MDRX) saw unusually-strong trading volume on Wednesday . 424,727 shares traded hands during mid-day trading, an increase of 172% from the previous session’s volume of 156,230 shares.The stock last traded at $4.90 and had previously closed at $4.95.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised shares of Veradigm to a “hold” rating in a report on Saturday, March 7th.

Veradigm Trading Down 1.0%

The stock has a 50-day moving average price of $4.73 and a 200 day moving average price of $4.66. The stock has a market capitalization of $599.27 million, a price-to-earnings ratio of 23.25 and a beta of 0.55.

Veradigm Company Profile

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.